| class name | count |
|---|---|
| asterids | 59 |
| Spermatophyta | 23 |
| Liliopsida | 15 |
| rosids | 12 |
| Embryophyta | 5 |
| Magnoliophyta | 4 |
| class name | count |
|---|---|
|
Asteraceae
|
20 |
|
Lamiaceae
|
16 |
|
Acanthaceae
|
13 |
|
Pinaceae
|
12 |
|
Zingiberaceae
|
12 |
|
Solanaceae
|
8 |
|
Cupressaceae
|
6 |
|
Jungermanniaceae
|
5 |
|
Aristolochiaceae
|
4 |
|
Cistaceae
|
4 |
|
Poaceae
|
3 |
|
Euphorbiaceae
|
2 |
|
Fabaceae
|
2 |
|
Cucurbitaceae
|
2 |
|
Taxaceae
|
2 |
|
Podocarpaceae
|
2 |
|
Polemoniaceae
|
2 |
|
Sapindaceae
|
1 |
|
Phaeosphaeriaceae
|
1 |
|
Araucariaceae
|
1 |
| br08003 Category | # of metabolite |
|---|---|
| Labdanes | 7 |
| br08003 Category | KEGG ID | KNApSAcK ID |
|---|---|---|
| Labdanes | C11901 | C00000876 |
| Labdanes | C06089 | C00000880 |
| Labdanes | C09183 | C00000894 |
| Labdanes | C11902 | C00000899 |
| Labdanes | C09124 | C00003449 |
| Labdanes | C20214 | C00023362 |
| Labdanes | C17498 | C00034848 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
figure |
|---|---|---|---|---|---|---|---|
|
C00000875
|
Labdenediol
/ 13E-Labdene-8alpha,15-diol |
CHEMBL589839
CHEMBL1644112 |
No. 118 |
|
|||
|
C00032497
|
(+)-(4->2)-abeo-Kolavelool-3-oic acid
|
No. 118 |
|
||||
|
C00032496
|
Deacetylrigidusol
/ (-)-Deacetylrigidusol |
No. 118 |
|
||||
|
C00000888
|
Peregrinol (diterpene)
|
CHEMBL589839
CHEMBL1644112 |
No. 118 |
|
|||
|
C00000894
|
13Z-Labdene-8alpha,15,16-triol
|
No. 118 |
|
||||
|
C00031964
|
(+)-13-epi-2alpha-Hydroxykolavelool
|
No. 118 |
|
||||
|
C00023460
|
(-)-2beta-Hydroxykolavelool
|
No. 118 |
|
||||
|
C00023459
|
ent-8(17),13E-Labdadien-9alpha,15-diol
|
No. 118 |
|
||||
|
C00023415
|
(+)-(9R*,13S*)-Dihydroxy-8(17),14-labdadiene
|
No. 118 |
|
||||
|
C00023341
|
[2S-[2alpha,3alpha,4abeta,5beta(S*),8aalpha]]-1,2,3,4,4a,5,8,8a-Octahydro-5-(3-hydroxy-3-methyl-4-pentenyl)-1,1,4a,6-tetramethyl-2,3-naphthalenediol
|
No. 118 |
|
||||
|
C00022241
|
2beta,8beta,15-Trihydroxy-ent-labd-13E-one
|
No. 118 |
|
||||
|
C00022245
|
ent-13E-Labdene-2alpha,3alpha,8alpha,15-tetrol
|
No. 118 |
|
||||
|
C00023336
|
[1S-[1alpha(S*),4abeta,7beta,8aalpha]]-alpha-Ethenyl-1,4,4a,5,6,7,8,8a-octahydro-7-hydroxy-a,2,5,5,8a-pentamethyl-1-naphthalenepropanol
|
No. 118 |
|
||||
|
C00022406
|
Abienol
|
CHEMBL603753
|
No. 118 |
|
|||
|
C00023334
|
7,14-Labdadiene-3alpha,13R-diol
|
No. 118 |
|
||||
|
C00023326
|
2-Ketoepimanool
|
No. 118 |
|
||||
|
C00023323
|
3alpha-Hydroxymanool
|
No. 118 |
|
||||
|
C00023322
|
7alpha-Hydroxymanool
/ (13R)-8(17),14-Labdadiene-7alpha,13-diol |
CHEMBL456311
CHEMBL1967786 |
No. 118 |
|
|||
|
C00023321
|
Larixol
|
CHEMBL1370284
|
5 / 7 / 37 | No. 118 |
|
||
|
C00023320
|
Torulosal
/ 13R-Hydroxy-8(17),14-labdadien-19-al |
No. 118 |
|
||||
|
C00023306
|
Manool
|
CHEMBL561922
|
No. 118 |
|
|||
|
C00022764
|
8alpha,15,18-Labdanetriol
|
No. 118 |
|
||||
|
C00022774
|
13-Epitorulosol
/ epi-13-Torulosol |
CHEMBL596905
CHEMBL1521278 |
3 / 15 / 12 | No. 118 |
|
||
|
C00022773
|
13-Epitorreferol
|
CHEMBL596905
CHEMBL1521278 |
3 / 15 / 12 | No. 118 |
|
||
|
C00022772
|
Torulosol
/ 8(17),14-Labdadiene-13R,19-diol |
CHEMBL596905
CHEMBL1521278 |
3 / 15 / 12 | No. 118 |
|
||
|
C00022723
|
Neoabienol
/ 11E,13E-Labdadien-8alpha-ol |
C085761
|
No. 118 |
|
|||
|
C00022724
|
(ent)-8-alpha-Hydroxy-13(16),14-labdadien-19-oic acid
|
No. 118 |
|
||||
|
C00022726
|
Sclareol
|
CHEMBL294740
CHEMBL464176 CHEMBL1369540 |
C070760
|
14 / 19 / 18 | No. 118 |
|
|
|
C00022729
|
13-Episclareol
/ 13-epi-Sclareol |
CHEMBL294740
CHEMBL464176 CHEMBL1369540 |
14 / 19 / 18 | No. 118 |
|
||
|
C00022730
|
Viteagnusin C
/ (-)-Viteagnusin C |
CHEMBL294740
CHEMBL464176 CHEMBL1369540 |
14 / 19 / 18 | No. 118 |
|
||
|
C00022731
|
ent-14-Gnaphalene-8beta,13S-diol
|
No. 118 |
|
||||
|
C00022732
|
Viteagnusin D
/ (+)-Viteagnusin D |
No. 118 |
|
||||
|
C00022750
|
Vitexifolin B
/ (+)-Vitexifolin B |
No. 118 |
|
||||
|
C00022752
|
Gymnospermin
|
No. 118 |
|
||||
|
C00022765
|
Torreferol
|
CHEMBL596905
CHEMBL1521278 |
3 / 15 / 12 | No. 118 |
|
||
|
C00022763
|
ent-8alpha,15-Labdanediol
|
CHEMBL1172098
|
No. 118 |
|
|||
|
C00045445
|
CPP
/ Copalyl diphosphate |
C090962
|
No. 118 |
|
|||
|
C00022762
|
7alpha,8-dihydroxy-5beta,8betaH,9betaH,10alpha-Labdan-15-oic acid
|
No. 256 |
|
||||
|
C00022720
|
(8alpha,11E,13S)-11,14-Labdadiene-8,13-diol
|
No. 256 |
|
||||
|
C00022719
|
(8alpha,11E,13R)-11,14-Labdadiene-8,13-diol
|
No. 256 |
|
||||
|
C00022718
|
13(16),14-Gnaphaladien-8alpha-ol
|
No. 256 |
|
||||
|
C00023210
|
epi-13-Manool
|
CHEMBL561922
|
No. 256 |
|
|||
|
C00023211
|
Vitexifolin A
|
CHEMBL561922
|
No. 256 |
|
|||
|
C00022716
|
18-Deoxyandalusol
|
No. 256 |
|
||||
|
C00022715
|
6-Deoxyandalusol
/ (ent-8alpha)-13(16),14-Labdadiene-8,18-diol |
No. 256 |
|
||||
|
C00022713
|
Isoabienol
|
No. 256 |
|
||||
|
C00022712
|
(8alphaH,9alpha,12E)-12,14-Labdadiene-9,18-diol
|
No. 256 |
|
||||
|
C00022711
|
6beta,18-Dihydroxy-12E-abienol
|
No. 256 |
|
||||
|
C00022519
|
6beta-Hydroxy-12E-abienol
/ (6beta,8alpha,12E)-12,14-Labdadiene-6,8-diol |
No. 256 |
|
||||
|
C00022473
|
18-Hydroxyabienol
/ (ent-8alpha)-12,14-Labdadiene-8,18-diol |
No. 256 |
|
||||
|
C00022717
|
Andalusol
|
CHEMBL2180484
|
1 / 0 / 0 | No. 256 |
|
||
|
C00045444
|
syn-CPP
/ syn-Copalyl diphosphate |
No. 256 |
|
||||
|
C00042658
|
ent-CPP
/ ent-Copalyl diphosphate |
No. 256 |
|
||||
|
C00040744
|
Zambesiacolactone A
/ (+)-Zambesiacolactone A |
No. 256 |
|
||||
|
C00040743
|
Methyl 8beta,17-epoxy-3beta,7beta,15-trihydroxy-12(E)-labden-16-oate
/ (+)-Methyl 8beta,17-epoxy-3beta,7beta,15-trihydroxy-12(E)-labden-16-oate |
No. 256 |
|
||||
|
C00040734
|
Aulacocarpin B
/ (+)-Aulacocarpin B |
CHEMBL461902
|
No. 256 |
|
|||
|
C00003449
|
8alpha-Hydroxy-13Z-labden-15-al
|
No. 256 |
|
||||
|
C00037007
|
Wightionolide
|
No. 256 |
|
||||
|
C00036293
|
14-Deoxyandrographolide
|
CHEMBL415768
|
No. 256 |
|
|||
|
C00033527
|
Andrographolide
|
CHEMBL186141
CHEMBL191892 CHEMBL364257 CHEMBL479285 CHEMBL466345 CHEMBL1317036 CHEMBL1317931 CHEMBL1599649 CHEMBL1705045 CHEMBL1951638 |
C030419
|
21 / 28 / 58 | 22 / 5 | No. 256 |
|
|
C00022255
|
cis-Abienol
|
CHEMBL603753
|
No. 660 |
|
|||
|
C00022232
|
13E-Labdene-3beta,8alpha,15-triol
|
No. 660 |
|
||||
|
C00023362
|
Labda-7,14-dien-13-ol
|
CHEMBL500040
|
No. 660 |
|
|||
|
C00041336
|
isoandrographolide
|
No. 660 |
|
||||
|
C00041244
|
8beta,17-Epoxy-3beta,7beta-Dihydroxy-12(E)-labden-16,15-olide
/ (+)-8beta,17-Epoxy-3beta,7beta-Dihydroxy-12(E)-labden-16,15-olide |
No. 660 |
|
||||
|
C00041241
|
Zambesiacolactone B
/ (+)-Zambesiacolactone B |
No. 660 |
|
||||
|
C00023363
|
Jungermanool
|
No. 660 |
|
||||
|
C00022230
|
ent-14-Labden-8beta-ol
|
No. 660 |
|
||||
|
C00022229
|
(8alpha,13E)-8,15-Dihydroxy-13-labden-19-al
|
No. 660 |
|
||||
|
C00038326
|
Aulacocarpin A
/ (+)-Aulacocarpin A |
CHEMBL518660
|
No. 660 |
|
|||
|
C00038155
|
12R,13R-Hydroxyandrographolide
|
CHEMBL518455
CHEMBL467963 CHEMBL467946 |
No. 660 |
|
|||
|
C00038156
|
12S-Hydroxyandrographolide
/ (-)-12S-Hydroxyandrographolide |
CHEMBL518455
CHEMBL467963 CHEMBL467946 |
No. 660 |
|
|||
|
C00038325
|
12S,13S-Hydroxyandrographolide
|
CHEMBL518455
CHEMBL467963 CHEMBL467946 |
No. 660 |
|
|||
|
C00037496
|
14-Deoxy-17-hydroxyandrographolide
/ (-)-14-Deoxy-17-hydroxyandrographolide |
CHEMBL479489
|
No. 1300 |
|
|||
|
C00034799
|
Andropanolide
/ (-)-Andropanolide |
CHEMBL186141
CHEMBL191892 CHEMBL364257 CHEMBL479285 CHEMBL466345 CHEMBL1317036 CHEMBL1317931 CHEMBL1599649 CHEMBL1705045 CHEMBL1951638 |
21 / 28 / 58 | No. 1300 |
|
||
|
C00036662
|
ent-2alpha-2,18-Dihydroxy-8(17),13-labdadien-15,16-olide
|
No. 1300 |
|
||||
|
C00034800
|
7R-Hydroxy-14-deoxyandrographolide
|
CHEMBL466745
CHEMBL512623 |
No. 1300 |
|
|||
|
C00034921
|
Phlogantholide A
|
No. 1300 |
|
||||
|
C00041603
|
Galanolactone
|
CHEMBL322730
|
C069419
|
No. 1300 |
|
||
|
C00034848
|
7S-Hydroxy-14-deoxyandrographolide
|
CHEMBL466745
CHEMBL512623 |
No. 1300 |
|
|||
|
C00034920
|
14-Deoxy-11-oxoandrographolide
|
No. 1300 |
|
||||
|
C00000880
|
Vulgarol
|
CHEMBL589839
CHEMBL1644112 |
No. 4186 |
|
|||
|
C00000899
|
8alpha-Hydroxy-13E-labden-15-al
|
No. 4186 |
|
||||
|
C00000876
|
Leoheteronin D
/ (+)-Leoheteronin D |
CHEMBL589839
CHEMBL1644112 |
No. 4186 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000894 C00022713 C00022717 C00022718 C00022719 C00023323 C00023362 C00032496 C00033527 C00041336 | 0 / 1 |
| P02545 | Prelamin-A/C | Unclassified protein | C00022717 C00022718 C00022719 C00023362 C00033527 C00041336 | 11 / 10 |
| Q99700 | Ataxin-2 | Unclassified protein | C00000894 C00023323 C00023362 C00032496 C00041336 | 1 / 1 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000894 C00023323 C00023362 C00032496 C00041336 | 2 / 0 |
| O00255 | Menin | Unclassified protein | C00000894 C00023323 C00023362 C00032496 C00041336 | 2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000894 C00023323 C00023362 C00032496 C00041336 | 1 / 2 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00022717 C00022718 C00022719 C00033527 | 4 / 1 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000894 C00023323 C00032496 | 0 / 1 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00000894 C00023323 C00032496 | 3 / 2 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000894 C00023323 C00032496 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00022752 C00023362 C00041336 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00000894 C00023323 C00032496 | 4 / 3 |
| P37840 | Alpha-synuclein | Unclassified protein | C00000894 C00023323 C00032496 | 4 / 2 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00000894 C00023323 C00032496 | 0 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000894 C00023323 C00032496 | 0 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00022713 C00023362 C00041336 | 7 / 37 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000894 C00023323 C00032496 | 1 / 1 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00000894 C00023323 C00032496 | 1 / 1 |
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00023362 C00041336 | 0 / 0 |
| P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00023362 C00041336 | 0 / 3 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00023362 C00041336 | 0 / 0 |
| Q9H227 | Cytosolic beta-glucosidase | Enzyme | C00023362 C00041336 | 0 / 0 |
| P31749 | RAC-alpha serine/threonine-protein kinase | Akt | C00023362 C00041336 | 4 / 1 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00023362 C00041336 | 0 / 0 |
| Q04206 | Transcription factor p65 | Transcription Factor | C00023362 C00041336 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00023362 C00041336 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00023362 C00041336 | 0 / 0 |
| P04278 | Sex hormone-binding globulin | Secreted protein | C00023362 C00041336 | 0 / 0 |
| O43451 | Maltase-glucoamylase, intestinal | Hydrolase | C00023362 C00041336 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00023362 C00041336 | 1 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00023362 C00041336 | 0 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00022713 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00022713 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00022713 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00023362
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00023362
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00023362
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00023362
|
| 890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00023362
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00023362
|
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00023362
|
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00023362
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00023362
|
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00023362
|
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00023362
|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00023362
|
| 54583 | EGLN1, C1orf12, ECYT3, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6 | egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) |
C00023362
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00023362
|
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00023362
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00023362
|
| 4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00023362
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00023362
|
| 259296 | TAS2R50, T2R50, T2R51, TAS2R51 | taste receptor, type 2, member 50 |
C00023362
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00023362
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00023362
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00023362
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #114480 | Breast cancer |
P31749
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P31749
P84022 |
| #615109 | Cowden syndrome 6; cws6 |
P31749
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #211980 | Lung cancer |
P04637
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P37840
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #176920 | Proteus syndrome |
P31749
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
| H00082 | Graves' disease |
P01215
(marker)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
P16473 (related) |
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
| H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
| H00018 | Gastric cancer |
P04637
(related)
|
| H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00022 | Bladder cancer |
P04637
(related)
|
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
| H00026 | Endometrial Cancer |
P04637
(related)
|
| H00027 | Ovarian cancer |
P04637
(related)
|
| H00028 | Choriocarcinoma |
P04637
(related)
|
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00031 | Breast cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
|
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00042 | Glioma |
P04637
(related)
P04637 (marker) |
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00046 | Cholangiocarcinoma |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|